Results for
"[search-keyword]"
Sponsor content
193 result(s) found, displaying 1 to 10
- Takeda Pharmaceuticals Australia Pty Ltd - Medication transfer set (419713)ARTGAustralian Register of Therapeutic Goods (ARTG) information for Takeda Pharmaceuticals Australia Pty Ltd - Medication transfer set.
- Takeda Pharmaceuticals Australia Pty Ltd - Subcutaneous/intramuscular injection set, medicated (414733)ARTGAustralian Register of Therapeutic Goods (ARTG) information for Takeda Pharmaceuticals Australia Pty Ltd - Subcutaneous/intramuscular injection set, medicated.
- AusPAR: LivtencityAustralian Public Assessment Report (AusPAR)AusPAR for Livtencity (maribavir) for the treatment of adults with post-transplant cytomegalovirus (CMV) infection and disease resistant, refractory or intolerant to one or more prior therapies
- ENTYVIO (Takeda Pharmaceuticals Australia Pty Ltd)Prescription medicine registrationActive ingredients: vedolizumab.
- TAKHZYRO Takeda Pharmaceuticals Australia Pty LtdJun-2023Prescription medicine evaluationActive ingredient: lanadelumab.
- AusPAR: ExkivityAustralian Public Assessment Report (AusPAR)AusPAR for Exkivity (Mobocertinib) for treatment of patients with locally advanced or metastatic non-small lung cancer.
- Notice for lanadelumab (Takeda Pharmaceuticals Australia Pty Ltd)Designation or determinationOrphan drug
- ADCETRIS Takeda Pharmaceuticals Australia Pty LtdJan-2023Prescription medicine evaluationActive ingredient: Brentuximab vedotin.
- Guanfacine 3 TAKEDA, guanfacine (as hydrochloride) 3 mg modified release tablet blister pack (395373)ARTGAustralian Register of Therapeutic Goods (ARTG) information for Guanfacine 3 TAKEDA, guanfacine (as hydrochloride) 3 mg modified release tablet blister pack.
- Guanfacine 4 TAKEDA, guanfacine (as hydrochloride) 4 mg modified release tablet blister pack (395374)ARTGAustralian Register of Therapeutic Goods (ARTG) information for Guanfacine 4 TAKEDA, guanfacine (as hydrochloride) 4 mg modified release tablet blister pack.